Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Gains 3%; BSE HEALTHCARE Index Up 1.0%
Tue, 10 Sep 12:4

Divis Laboratories Gains 3%; BSE HEALTHCARE Index Up 1.0%Image source: Kameleon007 /www.istockphoto.com

Divis Laboratories share price has zoomed 3% and is presently trading at Rs 5,346.0.

Meanwhile, the BSE HEALTHCARE index is at 43,787.7 (up 1.0%).

Among the top gainers in the BSE HEALTHCARE index today are FDC (up 6.8%) and LAURUS LABS (up 4.0%).

NARAYANA HRUDAYALAYA (down 1.8%) and ERIS LIFESCIENCES (down 1.7%) are among the top losers today.

Over the last one year, Divis Laboratories has moved up from Rs 3,709.1 to Rs 5,346.0, registering a gain of Rs 1,637.0 (up 44.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,357.7 to 43,787.7, registering a gain of 54.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 135.8%), Jubilant Pharmova (up 126.1%) and GRANULES INDIA (up 119.4%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,840.0 (up 0.3%).

The top gainers among the BSE Sensex today are Bharti Airtel (up 1.5%) and Infosys (up 1.4%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 25,024.6 (up 0.4%). LTIMINDTREE and Infosys are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,880.5 to 81,840.0, registering a gain of 15,959.5 points (up 24.2%).

Divis Laboratories Financial Update...

Divis Laboratories net profit grew 20.8% YoY to Rs 4,300 million for the quarter ended June 2024, compared to a profit of Rs 3,560 million a year ago. Net sales rose 19.1% to Rs 21,180 million during the period as against Rs 17,780 million in April-June 2023.

For the year ended March 2024, Divis Laboratories reported 12.3% decrease in net profit to Rs 16,000 million compared to net profit of Rs 18,240 million during FY23. Revenue of the company grew 1.0% to Rs 78,450 million during FY24.

The current Price to earnings ratio of Divis Laboratories, based on rolling 12 month earnings, stands at 84.8.


Equitymaster requests your view! Post a comment on "Divis Laboratories Gains 3%; BSE HEALTHCARE Index Up 1.0%". Click here!